United States · FDA National Drug Code directory

Oxy Bee Pollen Liquescence 3012

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63083-3012_1e7e4c97-92cf-4881-89cf-49e0e752822d
Product NDC: 63083-3012
Form: LIQUID
Composition / generic term: Oxy Bee Pollen Liquescence
Labeler: Professional Complementary Health Formulas
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 19840815
Source listing expiry: 20271231

Source-listed ingredients

BEE POLLEN — 2 [hp_X]/118mL
ENGLISH SOLE — 2 [hp_X]/118mL
DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA (M. TUBERCULOSIS) — 2 [hp_X]/118mL
BITTER ALMOND — 3 [hp_X]/118mL
FUCUS VESICULOSUS — 3 [hp_X]/118mL
LAMINARIA JAPONICA — 3 [hp_X]/118mL
MEDICAGO SATIVA WHOLE — 3 [hp_X]/118mL
ROYAL JELLY — 3 [hp_X]/118mL
ZINC — 4 [hp_X]/118mL
PANTOTHENIC ACID — 6 [hp_X]/118mL
COMFREY ROOT — 6 [hp_X]/118mL

These values do not establish equivalence or a dose recommendation.

Packages

118 mL in 1 BOTTLE, DROPPER (63083-3012-4) · 63083-3012-4

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →